IFUS Impact Fusion International Inc (PK)

Impact Fusion International Inc. (PINKSHEETS: IFUS) announces that the premier product of their Intact Nutrition™ Brand, Intact Digest™, is being promoted through the official website of the National Autism Association ("NAA").

A staggering 46% of autistic children experience digestive and GI tract disorders which further complicate autism spectrum symptoms. A 2002 study by Karoly Horvath and Jay Perman states, "Recent clinical studies have revealed a high prevalence of gastrointestinal symptoms, inflammation, and dysfunction in children with autism. Treatment of digestive problems appears to have positive effects on autistic behavior. These new observations represent only a piece of the unsolved autism 'puzzle' and should stimulate more research into the brain-gut connection." (http://www.springerlink.com/content/h02x77hu54672212/)

Marc Walther, CEO of Impact Fusion stated, "The NAA is committed to supporting research, available therapies, and possible cures for autism spectrum disorders. We believe 'Good Health Begins with Good Digestion' and we are proud to support this organization with both products and donations. We believe our contributions will help the NAA reach their goals of finding natural, effective therapies for the autistic community."

Impact Fusion International now proudly displays their products with the NAA, an organization working to further digestive health research and explore new supplemental therapies to help the autistic community.

For More Information Please Visit: http://www.nationalautismassociation.org

Read More: www.intactnutrition.com

Other Intact Nutrition™ Products: http://www.intactnutrition.com/total-health-products.html

Intact Digest™ with Nutri-Mastic™ is perfectly balanced with verified ionic minerals and Mastic Gum. This patent pending combination improves delivery of nutrients and enhances cellular absorption. Nutri-Mastic™ delivers anti-oxidant and anti-inflammatory properties while supporting digestive function, the immune system, vital organ health, healthy blood cells, the cardiac muscle and overall heart function.

About Impact Fusion International Inc. Impact Fusion International Inc. is in the business of marketing products in the "Health and Wellness" sector of all international markets. It is the company's mission to invent, develop and market these proprietary products worldwide for the health and well being of humans and animals.

This release may include projections of future results and "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable; it can give no assurances that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the expectations disclosed in this release, including, without limitation, in conjunction with those forward-looking statements contained in this release.

Reference: Horvath, Karoly & Perman, Jay A. "Autism and gastrointestinal symptoms." Current Gastroenterology Reports 4. 3(June 2002) http://www.springerlink.com/content/h02x77hu54672212/

Contacts: Impact Fusion International Inc. 1-866-716-6668 www.impactfusionintl.com